As amorfrutin B can selectively activate PPARγ without evoking adverse effects known for TZDs, in the current study, we aimed to assess the neuroprotective properties of amorfrutin B in a cellular model of stroke and perinatal asphyxia. Here, PPARG is linked to stroke disorder.